Your browser doesn't support javascript.
loading
Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study.
Karadurmus, Nuri; Paydas, Semra; Esin, Ece; Surmeli, Zeki Gokhan; Yildiz, Birol; Erturk, Ismail; Nayir, Erdinc; Dogan, Mutlu; Sumbul, Ahmet Taner; Barista, Ibrahim; Gurkan, Emel; Ocal, Ramazan; Ferhanoglu, Burhan; Ozgur, Gokhan; Karakas, Yusuf; Lacin, Sahin; Ozaydin, Sukru; Petekkaya, Halil Ibrahim; Uskent, Necdet.
Afiliación
  • Karadurmus N; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
  • Paydas S; Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Esin E; Department of Medical Oncology, Health Sciences University, Dr. Abdurrahman Yurtaslan Training and Research Hospital, Ankara, Turkey.
  • Surmeli ZG; Department of Medical Oncology, Medicalpark Hospital, Ankara, Turkey.
  • Yildiz B; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
  • Erturk I; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
  • Nayir E; Department of Medical Oncology, Medicalpark Hospital, Ankara, Turkey.
  • Dogan M; Department of Medical Oncology, Health Sciences University, Numune Training and Research Hospital, Ankara, Turkey.
  • Sumbul AT; Department of Medical Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.
  • Barista I; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Gurkan E; Department of Haematology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Ocal R; Department of Haematology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Ferhanoglu B; Department of Haematology, Faculty of Medicine, Koc University, Istanbul, Turkey.
  • Ozgur G; Department of Haematology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
  • Karakas Y; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Lacin S; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Ozaydin S; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
  • Petekkaya HI; Department of Medical Oncology, Special Tinaztepe Hospital, Izmir, Turkey.
  • Uskent N; Department of Medical Oncology, Anatolian Health Center, Istanbul, Turkey.
Arch Med Sci ; 17(4): 920-927, 2021.
Article en En | MEDLINE | ID: mdl-34336021
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Arch Med Sci Año: 2021 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Arch Med Sci Año: 2021 Tipo del documento: Article País de afiliación: Turquía